| 000 | 01815 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516165652.0 | ||
| 264 | 0 | _c20140421 | |
| 008 | 201404s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0071703 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPark, Noh Jin | |
| 245 | 0 | 0 |
_aMeasurement of cetuximab and panitumumab-unbound serum EGFR extracellular domain using an assay based on slow off-rate modified aptamer (SOMAmer) reagents. _h[electronic resource] |
| 260 |
_bPloS one _c2013 |
||
| 300 |
_ae71703 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAptamers, Nucleotide _xgenetics |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aCetuximab |
| 650 | 0 | 4 |
_aClinical Laboratory Techniques _xmethods |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPanitumumab |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptor, ErbB-3 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aReceptor, ErbB-4 |
| 650 | 0 | 4 | _aReproducibility of Results |
| 700 | 1 | _aWang, Xiuqiang | |
| 700 | 1 | _aDiaz, Angelica | |
| 700 | 1 | _aGoos-Root, Dana M | |
| 700 | 1 | _aBock, Christopher | |
| 700 | 1 | _aVaught, Jonathan D | |
| 700 | 1 | _aSun, Weimin | |
| 700 | 1 | _aStrom, Charles M | |
| 773 | 0 |
_tPloS one _gvol. 8 _gno. 8 _gp. e71703 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0071703 _zAvailable from publisher's website |
| 999 |
_c23046358 _d23046358 |
||